Marinomed Biotech AG

Major Shareholding Notification • Jun 1, 2023

Publication: 01.06.2023 16:00 Source: https://www.pressetext.com/news/20230601042 Keywords: Unternehmen / Beteiligungsmeldung / Marinomed Biotech AG

Holding announcement according to article 135 section 2 BörseG (ESMA 2015/1597)

Marinomed Biotech AG: Release according to article 135 section 2 BörseG

Korneuburg (pta/01.06.2023/16:00 UTC+2) - Release of Announcement according to article 135 section 2 BörseG

Notification of Major Holdings

1. Issuer

Marinomed Biotech AG, Hovengasse 25, 2100 Korneuburg, Austria

2. Reason for notification

Acquisition / disposal of shares with voting rights

3. Details of person subject to the notification obligation

Name: Abdulmohsen Al Sheikh

4. Names of shareholders, if different from declarants (3)

5. Date on which threshold was crossed or reached 30.05.2023

6. Total positions

	% of voting rights attached to shares (total of 7.a.)	% of voting rights through instruments (total of 7.b.1 + 7.b.2)	total of both in % (7.a. + 7.b.)	total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed / reached	5,19	0	5,19	1519167
Position of previous notification	13,86	n/a	13,86

7. Notified details of the resulting situation

7.A: Voting rights attached to shares

ISIN code	absolute direct (Sec 130 BörseG 2018)	absolute indirect (Sec 133 BörseG 2018)	in % direct (Sec 130 BörseG 2018)	in % indirect (Sec 133 BörseG 2018)
ATMARINOMED6 78845		0	5.19	0.00
Total:		78,845		5.19

7.B.1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018

type of	Maturity /	Exercise or conversion	Voting Rights	Voting Rights in
instrument	Expiration	period	Absolute	%
		Total:	0	0

7.B.2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018

type of	Maturity /	Exercise or	Cash or physical	Voting Rights	Voting Rights
instrument	Expiration	conversion period	transaction	Absolute	in %
			Total:	0	0

1. Information in relation to the person subject to the notification obligation

Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).

1. In case of proxy voting

Date of general meeting: N/A Voting rights after general meeting:

10. Other useful information

Die Beteiligungsmeldung erfolgt aufgrund der Schwellenüberschreitung wegen dem Erwerb von 78.845 Aktien.

Emitter:	Marinomed Biotech AG Hovengasse 25 2100 Korneuburg Austria
Contact Person:	Pascal Schmidt, CFO
Phone:	+43 2262 90300
E-Mail:	pascal.schmidt@marinomed.com
Website:	www.marinomed.com
ISIN(s):	ATMARINOMED6 (Share)
Stock Exchange(s):	Official Trade in Vienna

News transmitted by pressetext. The emitter is responsible for the content.